title: Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.
abstract: A novel series of dihydronaphthalene and benzosuberene analogs bearing structural similarity to the combretastatins in terms of 1,2-diarylethene, trimethoxyphenyl, and biaryl functionality has been synthesized. The compounds have been evaluated in regard to their ability to inhibit tubulin assembly and for their cytotoxicity against selected human cancer cell lines. From this series of compounds, benzosuberene analogs 2 and 4 inhibited tubulin assembly at concentrations comparable to that of combretastatin A-4 (CA4) and combretastatin A-1 (CA1). Furthermore, analog 4 demonstrated remarkable cytotoxicity against the three human cancer cell lines evaluated (for example GI(50)=0.0000032 microM against DU-145 prostate carcinoma).
authors: Department of Chemistry and Biochemistry, Baylor University, One Bear Place, Waco, TX 76798, USA.
authors: Madhavi
authors: M
authors: Sriram
authors: John J
authors: JJ
authors: Hall
authors: Nathan C
authors: NC
authors: Grohmann
authors: Tracy E
authors: TE
authors: Strecker
authors: Taylor
authors: T
authors: Wootton
authors: Andreas
authors: A
authors: Franken
authors: Mary Lynn
authors: ML
authors: Trawick
authors: Kevin G
authors: KG
authors: Pinney
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology*; D001567:Benzocycloheptenes / Q000138:chemical synthesis* / Q000737:chemistry; D001632:Bibenzyls / Q000737:chemistry* / Q000494:pharmacology; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D018360:Crystallography, X-Ray; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D009281:Naphthalenes / Q000138:chemical synthesis* / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014404:Tubulin / Q000187:drug effects* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D001567:Benzocycloheptenes; D001632:Bibenzyls; D009281:Naphthalenes; D014404:Tubulin; C040105:combretastatin